Edward J. Olhava

1 ta ish

Ifm Therapeutics (United States)

1. Targeting the NLRP3 inflammasome in inflammatory diseases

   Matthew Mangan, Edward J. Olhava, William Roush +3

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.443046